Efficacy and safety of lenalidomide in diffuse large B-cell lymphoma: a meta-analysis of randomized controlled trials

As an immunomodulatory agent with antitumor activity, lenalidomide has been evaluated for its value in diffuse large B-cell lymphoma (DLBCL). We performed a meta-analysis to gain a better understanding of the efficacy and safety of lenalidomide in DLBCL. PubMed, Cochrane Library, and Embase were sea...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Mi, Ruihua, Chen, Lin, Guo, Xiaoli, Liang, Taotao, Yin, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390621/
https://www.ncbi.nlm.nih.gov/pubmed/36315313
http://dx.doi.org/10.1007/s10238-022-00920-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390621/
https://www.ncbi.nlm.nih.gov/pubmed/36315313
http://dx.doi.org/10.1007/s10238-022-00920-2

Ejemplares similares